Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Bader

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncogene|August 21, 2007
Phosphorylation by Akt disables the anti-oncogenic activity of YB-1A G Bader, P K Vogt
Current Cancer Drug Targets|February 7, 2003
Molecular targets of the oncogenic transcription factor junM Hartl, A G Bader, K Bister
Virology|April 25, 2000
Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun alleleA G Bader, M Hartl, K Bister
Gene Therapy|June 3, 2011
Developing therapeutic microRNAs for cancerA G Bader, D Brown, J Stoudemire, et al.
Oncogene|December 26, 2001
TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1)A G Bader, M L Schneider, K Bister, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2001
JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesisM Hartl, F Reiter, A G Bader, et al.
Leukemia|April 24, 2012
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivoV J Craig, A Tzankov, M Flori, et al.
Oncogene|September 2, 2014
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancerA L Kasinski, K Kelnar, C Stahlhut, et al.
Oncogene|December 8, 2009
Regression of murine lung tumors by the let-7 microRNAP Trang, P P Medina, J F Wiggins, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncogene|August 21, 2007
Phosphorylation by Akt disables the anti-oncogenic activity of YB-1A G Bader, P K Vogt
Current Cancer Drug Targets|February 7, 2003
Molecular targets of the oncogenic transcription factor junM Hartl, A G Bader, K Bister
Virology|April 25, 2000
Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun alleleA G Bader, M Hartl, K Bister
Gene Therapy|June 3, 2011
Developing therapeutic microRNAs for cancerA G Bader, D Brown, J Stoudemire, et al.
Oncogene|December 26, 2001
TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1)A G Bader, M L Schneider, K Bister, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2001
JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesisM Hartl, F Reiter, A G Bader, et al.
Leukemia|April 24, 2012
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivoV J Craig, A Tzankov, M Flori, et al.
Oncogene|September 2, 2014
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancerA L Kasinski, K Kelnar, C Stahlhut, et al.
Oncogene|December 8, 2009
Regression of murine lung tumors by the let-7 microRNAP Trang, P P Medina, J F Wiggins, et al.
Pageof 1